Weill Cornell Medicine Events

Dean's Fourth Annual Symposium on Entrepreneurship and Academic Drug Development

This symposium is designed for faculty, trainees, and students interested in advancing their research from the lab to the clinic. 

Learn about ways to partner with industry and the resources available at BioPharma Alliances and Research Collaborations, the Tri-Institutional Therapeutics Discovery Institute, Bridge Medicines, and the Center for Technology Licensing.

 

Keynote Address by:

John Maraganore, PhD

Chief Executive Officer

Alnylam Pharmaceuticals

Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.

 

Featured Speakers:

John P. Leonard, MD

Senior Associate Dean for Innovation and Initiatives

Richard T. Silver Distinguished Professor of Hematology and Medical Oncology

Weill Cornell Medicine

"Updates on Weill Cornell Medicine's Innovation Ecosystem"

and

Li Gan, PhD

Director, Helen and Robert Appel Alzheimer’s Disease Research Institute

Burton P. and Judith B. Resnick Distinguished Professor in Neurodegenerative Diseases, Feil Family Brain and Mind Research Institute

Weill Cornell Medicine

"Developing New Therapeutics for Neurodegenerative Disease"

Thursday, October 22 at 4:30pm to 5:30pm

Event Type

Symposium

Departments

Office of the Dean, Tri-Institutional Therapeutics Discovery Institute, BioPharma Alliances and Research Collaborations, Dean's Entrepreneurship Lab

Mission

Research

Photo Alt Text

John Maraganore, Alnylam Pharmaceuticals

Is this a virtual event?

Yes

Virtual Event Registration URL

https://weillcornell.zoom.us/meeting/register/tJElc-usrT8jHtWyO0TMQKfPNNNKRFOrNL3A

Subscribe
Google Calendar iCal Outlook

Recent Activity